Merck Millipore launches Mobius 1000L

Published: 16-Feb-2012
Manufacturing

Single-use mixing and powder delivery system for the preparation of pharmaceutical ingredients

Merck Millipore, the life science division of Merck KGaA, had extended its Mobius mixer series with the addition of the Mobius MIX 1000 and powder delivery system for mixing pharmaceutical ingredients and preparing solutions. It joins a line of mixers that includes 100, 200 and 500 litre sizes.

The Mobius MIX 1000, which uses integrated, single-use powder delivery, mixing, and filtration technology, provides increased operational flexibility and decreases process and validation time and contamination risk, the US-based firm says.

‘We continue to drive innovation in single-use to ensure our customers have the flexibility they need for their manufacturing processes,’ says Paul Chapman, vice president, Biopharm Process Solutions at Merck Millipore.

The new single-use powder delivery container features a butterfly valve for controlled addition of solutes. Its asymmetric design enhances powder delivery by minimising clumping and blockage resulting in optimal powder flow and consistent mixing. The wash down ‘spraybar’ in the powder delivery container ensures that residual powder is effectively removed.

The 1000L uses the same quick-to-start bearingless levitating mixer technology that is the accepted standard within the industry at the 100, 200 and 500L scales. The stainless steel mixer carrier features a double jacket for the sides and the bottom for efficient heat exchange, thermowell for temperature measurement, as well as load cells for weight measurement.

Sampling ports integrated into the Mobius MIX containers provide closed sampling for maintaining product and sample integrity; zero dead-leg to ensure sample collected is representative of the bulk; NovaSeal crimper to easily disconnect the sampling container while maintaining sample and product integrity.

  • Companies:
  • Merck Electronics KGaA
See more

You may also like

Manufacturing

MilliporeSigma invests $25m into cell culture media

Read more
The subsidiary of Merck has announced the expansion of its facility in Lenexa, Kansas, adding 98,000 sqft of lab space in the process

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Why quality control should be intimately combined with sterile product development, manufacturing and the overall product supply chain With sponsor companies increasingly needing to create and launch differentiated, stable, usable and safe injectable treatments for patients, experts at ten23 health are keen to promote the importance of integrating development and/or manufacturing with quality control services
  2. Novo Nordisk invests DKK 8.5bn into new Danish modular production site This is the first time this century that Novo Nordisk has invested into its Danish production capabilities, with the site being capable of manufacturing product types within rare disease indications
  3. TekniPlex Healthcare to showcase expanded capacity and sustainability solutions at Pharmapack Company highlights EU-based advancements in injection blow molding, multilayer blown films, and sustainable blister packaging
  4. BioMarin Pharmaceutical expands Cork targeted therapy manufacturing facility with new lab The Irish facility is responsible for the development and commercialisation of therapies that address genetic conditions, and this expansion will allow the company to enhance its approved medicine production capacity
  5. Neuraxpharm Group and Pharmathen partner to develop long-lasting psychiatric injectables The co-development deal aims to enhance patient compliance, with Pharmathen and Neuraxpharm holding rights to the product in North America and Europe, respectively

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Manufacturing

MilliporeSigma invests $25m into cell culture media

The subsidiary of Merck has announced the expansion of its facility in Lenexa, Kansas, adding 98,000 sqft of lab space in the process
Manufacturing

Improving the operational efficiency of single-use assemblies in liquid bioprocessing

Merck recently announced the launch of its Ultimus Single-Use Process Container Film, which has been designed to provide extreme durability and leak resistance for the single-use assemblies used during bioprocessing liquid applications. Dr Kevin Robinson spoke to Greg Verni, Head of Single-Use and Systems, to find out more
Manufacturing

Merck opens commercial facility in France

The Martillac facility is designed to operate at the highest levels of efficiency and can rapidly pivot from 200 to 2000 litres of drug substance
Manufacturing

MilliporeSigma adds full viral vector contract services with new platform

This new launch has made it one of the first CDMOs and technology developers to provide a full viral vector manufacturing offering including AAV, Lentiviral, CDMO, CTO, and process development
Manufacturing

Merck opens $63m CDMO facility to handle HPAPIs

The industry expert has announced that its Life Science business sector has doubled its highly potent active pharmaceutical ingredients (HPAPI) production capacity with the expansion of this facility
Manufacturing

Merck expands technology and capacity for ADC manufacturing

“ADCs have experienced remarkable growth, with commercially approved ADCs tripling in the past three years”
Manufacturing

Merck launches bioprocessing 4.0 platform

The ProCellics Raman Analyzer and Bio4C Pat Raman software provide a module to build robust chemometric models
Subscribe now